587 related articles for article (PubMed ID: 16493615)
1. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
2. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia.
D'Alò F; Voso MT; Guidi F; Massini G; Scardocci A; Sica S; Pagano L; Hohaus S; Leone G
Haematologica; 2004 Jun; 89(6):664-70. PubMed ID: 15194533
[TBL] [Abstract][Full Text] [Related]
8. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
9. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
11. Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.
Eyada TK; El Ghonemy EG; El Ghoroury EA; El Bassyouni SO; El Masry MK
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):489-95. PubMed ID: 17581325
[TBL] [Abstract][Full Text] [Related]
12. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children.
Aplenc R
Pediatr Blood Cancer; 2004 Oct; 43(5):539-41. PubMed ID: 15382269
[No Abstract] [Full Text] [Related]
14. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
16. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
17. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
18. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia.
Majumdar S; Mondal BC; Ghosh M; Dey S; Mukhopadhyay A; Chandra S; Dasgupta UB
Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]